Radiotracer Development

Radiotracer Development is a multidisciplinary subfield of nuclear medicine and theranostics that focuses on the design, radiolabeling, optimization, and systematic preclinical and clinical validation of radiopharmaceutical probes so that they selectively interrogate or treat defined biological targets while exhibiting suitable pharmacokinetics, safety, and imaging or therapeutic performance.

2.2K

Publications

92.8K

Citations

9K

Authors

1.7K

Institutions

Publications per year

2017–2026

585

Authors

9K

  1. VW
    Victor W. Pike

    National Institute of Mental Health, United States

    62 publications · 2.8K citations

    28

    h-index

  2. CH
    Christer Halldin

    Karolinska Institutet, Sweden

    46 publications · 1.8K citations

    26

    h-index

  3. NV
    Neil Vasdev

    Harvard University, United States

    28 publications · 1.2K citations

    23

    h-index

  4. AA
    Alan A. Wilson

    Centre for Addiction and Mental Health, Canada

    29 publications · 1.9K citations

    22

    h-index

  5. MH
    M. H. Sanad

    Egyptian Atomic Energy Authority, Egypt

    30 publications · 969 citations

    21

    h-index

1–5 of 9K

Venues

  1. PubMed

    Repository · 152 publications · 10.4K citations

    55

    h-index

  2. Journal of Medicinal Chemistry

    147 publications · 6.4K citations

    47

    h-index

  3. Journal of Nuclear Medicine

    101 publications · 8.4K citations

    47

    h-index

  4. Bioconjugate Chemistry

    107 publications · 5.7K citations

    46

    h-index

  5. Nuclear Medicine and Biology

    NMB · 192 publications · 6.6K citations

    42

    h-index

1–5